FMT-Based Therapies for GI Disease: What to Consider FMT-Based Therapies for GI Disease: What to Consider
Dr Benjamin Levy highlights key considerations that need to be answered for FMT-based research to make good on its considerable promise.Medscape Gastroenterology (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - March 19, 2024 Category: Gastroenterology Tags: Gastroenterology Commentary Source Type: news

Evidence-Based Approach Recommended for Acute Pancreatitis Management
MONDAY, March 18, 2024 -- In a clinical guideline issued by the American College of Gastroenterology and published online in the March issue of the American Journal of Gastroenterology, evidence-based recommendations are presented for the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 18, 2024 Category: Pharmaceuticals Source Type: news

Gastrointestinal mucosal damages caused by ingestion of corrosive substances: a case study of hydrochloric acid and sodium hydroxide - Yusuf F, Abubakar A, Maghfirah D, Heltomi M, Isitua CC.
Ingestion of corrosive substances is most common in children, while in adults causes more severe damages. Massive ingestion of corrosive substances results in severe damage to the gastrointestinal tract and oropharynx if not treated properly. Corrosive sub... (Source: SafetyLit)
Source: SafetyLit - March 18, 2024 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news

Outbreak linked to morel mushroom exposure - Montana, 2023 - Demorest H, Hinnenkamp R, Cook-Shimanek M, Troeschel AN, Yeh M, Hallett TPC, Kuai D, Daniel J, Winquist A.
During March-April 2023, a total of 51 persons reported mild to severe gastrointestinal illness after eating at restaurant A in Bozeman, Montana. The outbreak resulted in multiple severe outcomes, including three hospitalizations and two deaths. After an i... (Source: SafetyLit)
Source: SafetyLit - March 16, 2024 Category: International Medicine & Public Health Tags: Home and Consumer Product Safety Source Type: news

Blood Test Has High Accuracy for Detecting CRC Blood Test Has High Accuracy for Detecting CRC
The test had relatively high sensitivity in an average-risk population, raising hopes that it could help increase screening rates among patients who decline stool tests or colonoscopies.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 15, 2024 Category: Consumer Health News Tags: Gastroenterology Source Type: news

Updated Guidance Supports FMT for CDI, But Not IBD or IBS Updated Guidance Supports FMT for CDI, But Not IBD or IBS
Based on a synthesis of best available evidence, the AGA released clinical recommendations on fecal microbiota-based therapies in adults with gastrointestinal diseases.MDedge News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - March 15, 2024 Category: Gastroenterology Tags: Gastroenterology Source Type: news

Fecal Incontinence: One in 12 Adults May Be Affected Fecal Incontinence: One in 12 Adults May Be Affected
Approximately one in 12 adults worldwide has fecal incontinence, according to a recent global meta-analysis.MDedge News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - March 15, 2024 Category: Gastroenterology Tags: Gastroenterology Source Type: news

FDA Approves First Drug for MASH FDA Approves First Drug for MASH
Resmetirom, a thyroid hormone receptor beta-selective agonist, is the first FDA-approved medication for MASH with moderate to advanced liver fibrosis.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - March 14, 2024 Category: Internal Medicine Tags: Gastroenterology Source Type: news

The Next Gen of Smart Pills Will Transform Personalized Care The Next Gen of Smart Pills Will Transform Personalized Care
From detecting overdoses in real time to assuring family members that their loved ones are taking their meds, here ' s how scientists are reimagining the humble pill.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - March 14, 2024 Category: Gastroenterology Tags: Gastroenterology Source Type: news

First Wave BioPharma Completes Merger Deal With ImmunogenX Adding Phase 3-Ready Candidate For Celiac Disease
First Wave BioPharma Inc FWBI has acquired ImmunogenX in an all-stock transaction with the combined company focused on advancing a gastrointestinal (GI) pipeline. First Wave BioPharma signed a non-binding term sheet in December to acquire ImmunogenX. James Sapirstein will continue to serve as…#firstwave #biopharmainc #firstwavebiopharma #jamessapirstein #jacksyage #sapirstein #gidivision #fda #immunogenx #niclosamide (Source: Reuters: Health)
Source: Reuters: Health - March 14, 2024 Category: Consumer Health News Source Type: news

US Insurers Out of Step With IBD Treatment Guidelines US Insurers Out of Step With IBD Treatment Guidelines
Most US insurance companies require patients to fail conventional therapies for Crohn ' s disease and ulcerative colitis before they will cover a biologic agent, contrary to treatment guidelines.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - March 14, 2024 Category: Gastroenterology Tags: Gastroenterology Source Type: news

US FDA Approves Expanded Use Of Mirum's Liver Disease Drug US FDA Approves Expanded Use Of Mirum's Liver Disease Drug
The U.S Food and Drug Administration has approved the expanded use of Mirum Pharmaceuticals ' oral drug to treat itching caused by a liver disorder in patients aged five...Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - March 13, 2024 Category: Gastroenterology Tags: Gastroenterology Source Type: news

Half of GI Docs Would Give Up Money for Work-Life Balance Half of GI Docs Would Give Up Money for Work-Life Balance
Navigating the intense demands of work with their own needs for a better work-life balance is a constant struggle for gastroenterologists, according to the latest Medscape survey.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - March 13, 2024 Category: Gastroenterology Tags: Gastroenterology Source Type: news

Ionis Pharma's Fatty Liver Disease Drug Succeeds in Mid-stage Trial Ionis Pharma's Fatty Liver Disease Drug Succeeds in Mid-stage Trial
Ionis Pharmaceuticals said on Wednesday its experimental drug to treat a type of fatty liver disease met the main goal of reducing inflammation of the critical organ in a...Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - March 13, 2024 Category: Gastroenterology Tags: Gastroenterology Source Type: news

Prevalence of Increased Residual Gastric Content Increased With GLP-1 RAs
TUESDAY, March 12, 2024 -- Use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a higher prevalence of increased residual gastric content (RGC), according to a study published online March 6 in JAMA Surgery. Sudipta Sen,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 12, 2024 Category: Pharmaceuticals Source Type: news